Introduction
Professor Cheng Shuqun (程树群) is a Professor of Hepatobiliary Surgery at Eastern Hepatobiliary Surgery Hospital (EHBH), affiliated with Naval Medical University — the world's largest and most specialized hepatobiliary surgery center. Professor Cheng is widely recognized as one of China's foremost experts in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) — one of the most challenging and feared complications of liver cancer. His pioneering work in developing surgical and multimodal treatment strategies for HCC with PVTT has transformed the management of this condition in China and internationally, offering hope to patients previously considered untreatable. International patients with advanced liver cancer, particularly HCC with portal vein involvement, consistently regard Professor Cheng as one of the world's leading experts in this highly specialized field.
Academic Distinctions & Leadership
- Professor of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University
- Member, Chinese Society of Surgery, Hepatobiliary Surgery Branch
- Member, Chinese Anti-Cancer Association, Liver Cancer Committee
- Portal Vein Tumor Thrombus Expert Committee Member, Chinese Anti-Cancer Association
- Member, International Hepato-Pancreato-Biliary Association (IHPBA)
- Editorial Board Member, multiple Chinese and international hepatobiliary surgery and oncology journals
- Recipient, multiple national and Shanghai municipal science and technology awards
- Visiting professor at leading liver surgery centers internationally
Specializations & Expertise
HCC with Portal Vein Tumor Thrombus (PVTT)
- Surgical resection for HCC with PVTT (all types: Vp1-Vp4)
- Thrombectomy combined with liver resection
- Preoperative TACE + surgery for HCC with PVTT
- Preoperative radiotherapy + surgery for HCC with PVTT
- Systemic therapy + surgery (conversion) for HCC with PVTT
- Postoperative adjuvant therapy for PVTT recurrence prevention
- Management of HCC with hepatic vein and IVC tumor thrombus
Advanced Liver Cancer Surgery
- Major hepatectomy for large and multifocal HCC
- Repeat liver resection for recurrent HCC
- Conversion surgery after downstaging therapy
- Surgery for HCC with bile duct tumor thrombus
- Surgery for HCC with hepatic vein involvement
- Associating liver partition and portal vein ligation (ALPPS) for small liver remnant
Standard Liver Cancer Surgery
- Anatomical liver resection (segmentectomy, hemihepatectomy)
- Laparoscopic liver resection
- Non-anatomical liver resection
- Intrahepatic cholangiocarcinoma surgery
- Colorectal liver metastasis resection
Multimodal Liver Cancer Treatment
- TACE (transarterial chemoembolization) coordination
- Hepatic arterial infusion chemotherapy (HAIC)
- Targeted therapy (sorafenib, lenvatinib) coordination
- Immunotherapy (PD-1 inhibitors) coordination
- Radiotherapy for PVTT coordination
- Ablation therapy (RFA, MWA) coordination
Clinical Excellence & Innovation
Professor Cheng Shuqun has performed thousands of liver cancer surgeries throughout his distinguished career, with a particular reputation as China's leading authority on HCC with portal vein tumor thrombus. His work has fundamentally changed the treatment paradigm for this condition in China.
- PVTT Surgery Pioneer: Established China's most comprehensive surgical program for HCC with portal vein tumor thrombus, demonstrating that selected patients with PVTT can achieve long-term survival with aggressive surgical management
- Chinese PVTT Guidelines: Led the development of China's national expert consensus guidelines for the management of HCC with portal vein tumor thrombus, which are now widely adopted across China
- Multimodal PVTT Treatment: Pioneered combined approaches integrating preoperative TACE, radiotherapy, targeted therapy, and immunotherapy with surgery for HCC with PVTT
- ALPPS Procedure: Experience with Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) for patients with insufficient liver remnant
- Conversion Surgery: Expert in achieving surgical resection after successful downstaging of initially unresectable HCC with PVTT
Research & Academic Contributions
Professor Cheng is one of China's most prolific liver cancer researchers with numerous peer-reviewed publications in leading Chinese and international journals including Journal of Hepatology, Hepatology, Journal of Clinical Oncology, and Annals of Surgery. His research focuses on HCC with PVTT management, multimodal treatment strategies, and conversion surgery.
Major research contributions include:
- Surgical outcomes for HCC with different types of portal vein tumor thrombus
- Chinese expert consensus on management of HCC with portal vein tumor thrombus
- Preoperative TACE combined with surgery for HCC with PVTT
- Radiotherapy combined with surgery for HCC with PVTT
- Immunotherapy plus targeted therapy as conversion strategy for unresectable HCC with PVTT
Hospital Affiliation
Eastern Hepatobiliary Surgery Hospital (EHBH), Naval Medical University
225 Changhai Road, Yangpu District, Shanghai 200438
Eastern Hepatobiliary Surgery Hospital is the world's largest and most specialized hepatobiliary surgery center, performing over 10,000 hepatobiliary surgeries annually. The hospital features:
- World's highest-volume hepatobiliary surgery program
- Dedicated PVTT multidisciplinary team
- State-of-the-art hepatobiliary operating rooms
- Comprehensive liver cancer MDT including hepatologists, interventional radiologists, radiation oncologists, and medical oncologists
- Advanced liver imaging and interventional radiology
- International patient services with English-speaking coordinators
Patient Care Philosophy
- Aggressive but Rational: Pursues surgical resection for HCC with PVTT when patient selection criteria are met, while avoiding futile surgery
- Multimodal Integration: Combines surgery with TACE, radiotherapy, targeted therapy, and immunotherapy for optimal outcomes
- Conversion Strategy: Actively pursues downstaging to achieve resection in initially unresectable cases
- Multidisciplinary Decision-Making: All advanced HCC cases reviewed by a comprehensive MDT
- Evidence-Based Practice: All decisions guided by the latest international and Chinese liver cancer guidelines
- Honest Prognosis: Clear communication about realistic outcomes and treatment goals
Why Choose Professor Cheng Shuqun?
- World's Leading PVTT Expert: China's foremost authority on HCC with portal vein tumor thrombus surgery
- Guideline Author: Led development of China's national PVTT management guidelines
- Hope for Advanced Cases: Offers surgical options for patients with HCC and PVTT often declined elsewhere
- Multimodal Expertise: Comprehensive integration of surgery with systemic and locoregional therapies
- World's Largest Liver Surgery Center: Eastern Hepatobiliary Surgery Hospital's unmatched volume and expertise
- Cost-Effective Excellence: Advanced liver cancer treatment costs in Shanghai are typically 65-80% lower than in the US or Europe
- Proven International Track Record: Trusted by patients from around the world
Conditions Treated
Advanced Liver Cancer
- HCC with portal vein tumor thrombus (Vp1-Vp4)
- HCC with hepatic vein tumor thrombus
- HCC with IVC tumor thrombus
- HCC with bile duct tumor thrombus
- Large and multifocal HCC
- Recurrent HCC after prior treatment
- Initially unresectable HCC (conversion candidates)
Standard Liver Cancer
- Hepatocellular carcinoma (all stages)
- Intrahepatic cholangiocarcinoma
- Colorectal liver metastases
International Patient Services
China Medical Concierge - Shanghai (CMCS) provides comprehensive support for international patients seeking liver cancer surgery with Professor Cheng Shuqun at Eastern Hepatobiliary Surgery Hospital.
Pre-Arrival Support
- Medical Record Review: Review of your liver MRI, CT, AFP, liver function tests, and prior treatment history
- Virtual Consultation: Video consultation with Professor Cheng's team to discuss your liver cancer and PVTT status
- MDT Review: Arrangement of multidisciplinary team review including PVTT specialists
- Resectability Assessment: Expert evaluation of surgical candidacy and optimal treatment strategy
- Cost Transparency: Detailed cost estimate including consultations, surgery, and hospitalization
- Visa Assistance: Medical visa guidance and invitation letters
- Travel Arrangements: Flights, airport pickup, and accommodation near the hospital
During Treatment
- Professional Medical Interpretation: Experienced hepatobiliary surgery interpreters at all appointments
- Hospital Navigation Support: Registration, payment, and hospital navigation assistance
- Pre-operative Assessment: Comprehensive staging, liver function assessment, and treatment planning
- Surgical Support: Accompaniment and family support on surgery day
- 24/7 Support: Round-the-clock assistance for any concerns
Post-Treatment Care
- Pathology Report Translation: Complete translation of surgical pathology reports
- Treatment Summary: Comprehensive summary for your home oncologist and hepatologist
- Adjuvant Therapy Coordination: Guidance on recommended adjuvant therapy for PVTT recurrence prevention
- Surveillance Plan: AFP monitoring and imaging surveillance schedule
- Telemedicine Follow-up: Virtual follow-up with Professor Cheng's team
- Long-term Support: Ongoing assistance after returning home
Schedule Your Consultation
If you or a loved one has hepatocellular carcinoma with portal vein tumor thrombus, advanced liver cancer, or a liver condition that has been deemed inoperable elsewhere, Professor Cheng Shuqun at Eastern Hepatobiliary Surgery Hospital offers world-class expertise at a fraction of Western costs.
Contact China Medical Concierge - Shanghai today to request a liver imaging review, schedule a virtual consultation, and find out if surgery is an option for your liver cancer.
Bridging international patients with Shanghai's finest liver cancer surgeons — offering hope for advanced liver cancer at the world's largest hepatobiliary surgery center.
0 commenti